Francesca Macera
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Francesca Macera has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
Ana Roussoulières
CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium
2 shared publicationsAntoine Bondue
CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium
2 shared publicationsCéline Dewachter
CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium
2 shared publications- Ersilia M. DeFilippis
Center for Advanced Cardiac Care, Division of Cardiology, Columbia University Irving Medical Center, New York, New York, USA
2 shared publications Jean-Luc Vachiéry
CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium
2 shared publicationsAlessandro Verde
De Gasperis Cardio Center, Niguarda Hospital, Milan, Italy (E.A., P.G., L.D., G.M., A.V., F. Macera, D.B., L.O., F. Musca, E.P., A.M., F.O., A.G.).
1 shared publication
Latest Publications
- 1 February 2024
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 17 (2) , e010973
Estimation of Right Atrial Pressure by Ultrasound-Assessed Jugular Vein Distensibility in Patients With Heart Failure
BACKGROUND: Clinical evaluation of central venous pressure is difficult, depends on experience, and is often inaccurate in patients with chronic advanced heart failure. We assessed the ultrasound-assessed internal jugular vein (JV) distensibility by ultrasound as a noninvasive tool to identify patients with normal right atrial pressure (RAP ≤7 mm Hg) in this population. METHODS: We measured JV distensibility as the Valsalva-to-rest ratio of the vein diameter in a calibration cohort (N=100) and a validation cohort (N=101) of consecutive patients with chronic heart failure with reduced ejection fraction who underwent pulmonary artery catheterization for advanced heart failure therapies workup. RESULTS: A JV distensibility threshold of 1.6 was identified as the most accurate to discriminate between patients with RAP ≤7 versus >7 mm Hg (area under the receiver operating characteristic curve, 0.74 [95% CI, 0.64–0.84]) and confirmed in the validation cohort (receiver operating characteristic, 0.82 [95% CI, 0.73–0.92]). A JV distensibility ratio >1.6 had predictive positive values of 0.86 and 0.94, respectively, to identify patients with RAP ≤7 mm Hg in the calibration and validation cohorts. Compared with patients from the calibration cohort with a high JV distensibility ratio (>1.6; n=42; median RAP, 4 mm Hg; pulmonary capillary wedge pressure, 11 mm Hg), those with a low JV distensibility ratio (≤1.6; n=58; median RAP, 8 mm Hg; pulmonary capillary wedge pressure, 22 mm Hg; P P =0.034). CONCLUSIONS: Ultrasound-assessed JV distensibility identifies patients with chronic advanced heart failure with normal RAP and better outcomes. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03874312.
- 1 February 2024
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 17 (2) , e010973
Estimation of Right Atrial Pressure by Ultrasound-Assessed Jugular Vein Distensibility in Patients With Heart Failure
BACKGROUND: Clinical evaluation of central venous pressure is difficult, depends on experience, and is often inaccurate in patients with chronic advanced heart failure. We assessed the ultrasound-assessed internal jugular vein (JV) distensibility by ultrasound as a noninvasive tool to identify patients with normal right atrial pressure (RAP ≤7 mm Hg) in this population. METHODS: We measured JV distensibility as the Valsalva-to-rest ratio of the vein diameter in a calibration cohort (N=100) and a validation cohort (N=101) of consecutive patients with chronic heart failure with reduced ejection fraction who underwent pulmonary artery catheterization for advanced heart failure therapies workup. RESULTS: A JV distensibility threshold of 1.6 was identified as the most accurate to discriminate between patients with RAP ≤7 versus >7 mm Hg (area under the receiver operating characteristic curve, 0.74 [95% CI, 0.64–0.84]) and confirmed in the validation cohort (receiver operating characteristic, 0.82 [95% CI, 0.73–0.92]). A JV distensibility ratio >1.6 had predictive positive values of 0.86 and 0.94, respectively, to identify patients with RAP ≤7 mm Hg in the calibration and validation cohorts. Compared with patients from the calibration cohort with a high JV distensibility ratio (>1.6; n=42; median RAP, 4 mm Hg; pulmonary capillary wedge pressure, 11 mm Hg), those with a low JV distensibility ratio (≤1.6; n=58; median RAP, 8 mm Hg; pulmonary capillary wedge pressure, 22 mm Hg; P P =0.034). CONCLUSIONS: Ultrasound-assessed JV distensibility identifies patients with chronic advanced heart failure with normal RAP and better outcomes. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03874312.
- Open Access
- 17 December 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (24) , 7743
Effects of High-Intensity Interval Training Using the 3/7 Resistance Training Method on Metabolic Stress in People with Heart Failure and Coronary Artery Disease: A Randomized Cross-Over Study
The 3/7 resistance training (RT) method involves performing sets with increasing numbers of repetitions, and shorter rest periods than the 3x9 method. Therefore, it could induce more metabolic stress in people with heart failure with reduced ejection fraction (HFrEF) or coronary artery disease (CAD). This randomized cross-over study tested this hypothesis. Eleven individuals with HFrEF and thirteen with CAD performed high-intensity interval training (HIIT) for 30 min, followed by 3x9 or 3/7 RT according to group allocation. pH, HCO3−, lactate, and growth hormone were measured at baseline, after HIIT, and after RT. pH and HCO3− decreased, and lactate increased after both RT methods. In the CAD group, lactate increased more (6.99 ± 2.37 vs. 9.20 ± 3.57 mmol/L, p = 0.025), pH tended to decrease more (7.29 ± 0.06 vs. 7.33 ± 0.04, p = 0.060), and HCO3− decreased more (18.6 ± 3.1 vs. 21.1 ± 2.5 mmol/L, p = 0.004) after 3/7 than 3x9 RT. In the HFrEF group, lactate, pH, and HCO3− concentrations did not differ between RT methods (all p > 0.248). RT did not increase growth hormone in either patient group. In conclusion, the 3/7 RT method induced more metabolic stress than the 3x9 method in people with CAD but not HFrEF.
- 17 December 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (24) , 7743
Open AccessEffects of High-Intensity Interval Training Using the 3/7 Resistance Training Method on Metabolic Stress in People with Heart Failure and Coronary Artery Disease: A Randomized Cross-Over Study
The 3/7 resistance training (RT) method involves performing sets with increasing numbers of repetitions, and shorter rest periods than the 3x9 method. Therefore, it could induce more metabolic stress in people with heart failure with reduced ejection fraction (HFrEF) or coronary artery disease (CAD). This randomized cross-over study tested this hypothesis. Eleven individuals with HFrEF and thirteen with CAD performed high-intensity interval training (HIIT) for 30 min, followed by 3x9 or 3/7 RT according to group allocation. pH, HCO3−, lactate, and growth hormone were measured at baseline, after HIIT, and after RT. pH and HCO3− decreased, and lactate increased after both RT methods. In the CAD group, lactate increased more (6.99 ± 2.37 vs. 9.20 ± 3.57 mmol/L, p = 0.025), pH tended to decrease more (7.29 ± 0.06 vs. 7.33 ± 0.04, p = 0.060), and HCO3− decreased more (18.6 ± 3.1 vs. 21.1 ± 2.5 mmol/L, p = 0.004) after 3/7 than 3x9 RT. In the HFrEF group, lactate, pH, and HCO3− concentrations did not differ between RT methods (all p > 0.248). RT did not increase growth hormone in either patient group. In conclusion, the 3/7 RT method induced more metabolic stress than the 3x9 method in people with CAD but not HFrEF.
- 13 December 2023
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 43 (5) , 727-736
Informing preconception counseling: Outcomes among female heart transplant recipients in the ISHLT registry
- 13 December 2023
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 43 (5) , 727-736
Informing preconception counseling: Outcomes among female heart transplant recipients in the ISHLT registry
- 9 September 2023
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 62 (suppl 67) , PA3959
Biomarkers of angiogenesis in pulmonary arterial hypertension and pulmonary hypertension due to left heart diseases
Pulmonary arterial hypertension (PAH) and pulmonary hypertension due to left heart diseases (PH-LHD) are distinct conditions but may share some features when a combined pre and post-capillary PH (CpcPH) is present. We analysed biomarkers of vasoconstriction (endothelin-1, ET1) and angiogenesis [angiopoietin (Ang) 1 and 2; Tie2 receptor] in PAH and LHD, and correlation with PH severity Methods: We included 55 patients undergoing a right heart catheterization for LHD or suspicion of PH. Blood samples were analysed for biomarkers Results: 37 patients had LHD (18 CpcPH) and 16 PAH. PH was more severe in PAH than in PH-LHD or CpcPH. No differences in ET1, Ang2 or Tie2 were observed between PH-LHD and PAH. Ang1 was higher in PAH than PH-LHD (fig1) or CpcPH (p=0.025). In PAH, Ang1 correlated with pulmonary vascular resistance, PVR and pulmonary artery compliance, CPA. In LHD, PVR and CPA correlated with Ang2 and ET1 (fig2) Conclusion: In PAH, Ang1 is higher than in PH-LHD and correlates with PVR and CPA. In LHD, its antagonist Ang2 correlates with PVR and CPA, suggesting that angiogenesis may be differently activated in these conditions
- 9 September 2023
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 62 (suppl 67) , PA3959
Biomarkers of angiogenesis in pulmonary arterial hypertension and pulmonary hypertension due to left heart diseases
Pulmonary arterial hypertension (PAH) and pulmonary hypertension due to left heart diseases (PH-LHD) are distinct conditions but may share some features when a combined pre and post-capillary PH (CpcPH) is present. We analysed biomarkers of vasoconstriction (endothelin-1, ET1) and angiogenesis [angiopoietin (Ang) 1 and 2; Tie2 receptor] in PAH and LHD, and correlation with PH severity Methods: We included 55 patients undergoing a right heart catheterization for LHD or suspicion of PH. Blood samples were analysed for biomarkers Results: 37 patients had LHD (18 CpcPH) and 16 PAH. PH was more severe in PAH than in PH-LHD or CpcPH. No differences in ET1, Ang2 or Tie2 were observed between PH-LHD and PAH. Ang1 was higher in PAH than PH-LHD (fig1) or CpcPH (p=0.025). In PAH, Ang1 correlated with pulmonary vascular resistance, PVR and pulmonary artery compliance, CPA. In LHD, PVR and CPA correlated with Ang2 and ET1 (fig2) Conclusion: In PAH, Ang1 is higher than in PH-LHD and correlates with PVR and CPA. In LHD, its antagonist Ang2 correlates with PVR and CPA, suggesting that angiogenesis may be differently activated in these conditions
- Open Access
- 22 December 2022
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 10 (2) , 1043-1053
Lung Diffusion Capacity Correlates with Pre-Implant Pulmonary Hypertension and Predicts Outcome After LVAD Implantation
Aims: Diffusing capacity of the lung for carbon monoxide (DLCO) reduction is common in heart failure (HF) and is associated with a worse prognosis. Correlations between DLCO and pulmonary hypertension (PH) are unclear, and published data are conflicting; it has been shown that DLCO impairment may persist or even worsen after normalization of pulmonary pressures following left ventricle assist device (LVAD) implantation, maybe reflecting persistent pulmonary damage. We aimed to investigate the impact of pre-implant DLCO and central haemodynamics on outcome in patients with advanced HF implanted with a LVAD. Methods and results: We retrospectively analysed pre-implant and post-implant data from 42 patients implanted with a LVAD at our institution. Out of 42 patients, 35 had post-capillary PH before implantation, including 17 with combined post- and pre-capillary PH (Cpc-PH). Median DLCO was 59% (IQR 47–68%), and it inversely correlated with pulmonary vascular resistance (PVR) (P 0.037) and diastolic pulmonary gradient (DPG) (P 0.042). Compared with baseline, LVAD resulted in improvement in LV diameter (LVDd, P < 0.001), mitral regurgitation (P 0.022), and PH (mPAP 24 vs. 36 mmHg, P < 0.001; PAWP 12 vs. 23 mmHg, P 0.001; pulmonary artery compliance, CPA 3.1 vs. 1.9 mL/mmHg, P 0.021). Lower DLCO and Cpc-PH at baseline were associated with a better LV reverse remodelling post-implantation (P 0.027 for LVDd) but also with a smaller gain in CPA (P 0.049). Conclusions: Before LVAD implantation, DLCO impairment is associated with higher PVR and DPG, suggesting that it might be an expression of persistent pulmonary damage occurring in Cpc-PH. After LVAD implantation, both LV dimension and haemodynamics improve. Lower pre-implant DLCO is associated with better LV reverse remodelling.
- 22 December 2022
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 10 (2) , 1043-1053
Open AccessLung Diffusion Capacity Correlates with Pre-Implant Pulmonary Hypertension and Predicts Outcome After LVAD Implantation
Aims: Diffusing capacity of the lung for carbon monoxide (DLCO) reduction is common in heart failure (HF) and is associated with a worse prognosis. Correlations between DLCO and pulmonary hypertension (PH) are unclear, and published data are conflicting; it has been shown that DLCO impairment may persist or even worsen after normalization of pulmonary pressures following left ventricle assist device (LVAD) implantation, maybe reflecting persistent pulmonary damage. We aimed to investigate the impact of pre-implant DLCO and central haemodynamics on outcome in patients with advanced HF implanted with a LVAD. Methods and results: We retrospectively analysed pre-implant and post-implant data from 42 patients implanted with a LVAD at our institution. Out of 42 patients, 35 had post-capillary PH before implantation, including 17 with combined post- and pre-capillary PH (Cpc-PH). Median DLCO was 59% (IQR 47–68%), and it inversely correlated with pulmonary vascular resistance (PVR) (P 0.037) and diastolic pulmonary gradient (DPG) (P 0.042). Compared with baseline, LVAD resulted in improvement in LV diameter (LVDd, P < 0.001), mitral regurgitation (P 0.022), and PH (mPAP 24 vs. 36 mmHg, P < 0.001; PAWP 12 vs. 23 mmHg, P 0.001; pulmonary artery compliance, CPA 3.1 vs. 1.9 mL/mmHg, P 0.021). Lower DLCO and Cpc-PH at baseline were associated with a better LV reverse remodelling post-implantation (P 0.027 for LVDd) but also with a smaller gain in CPA (P 0.049). Conclusions: Before LVAD implantation, DLCO impairment is associated with higher PVR and DPG, suggesting that it might be an expression of persistent pulmonary damage occurring in Cpc-PH. After LVAD implantation, both LV dimension and haemodynamics improve. Lower pre-implant DLCO is associated with better LV reverse remodelling.
- 26 October 2022
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 42 (3) , e1-e42
Reproductive health after thoracic transplantation: An ISHLT expert consensus statement
- 26 October 2022
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 42 (3) , e1-e42
Reproductive health after thoracic transplantation: An ISHLT expert consensus statement